Childrens Acetaminophen
NDC Package 59999-001-04
Package Information
Childrens Acetaminophen is do not give more than directed (see Liver and overdose warning)shake well before usethis product does not contain directions or complete warnings for adult useuse only with enclosed dosing cuprepeat dose every 4 hours if neededdo not give more than 5 times in 24 hoursdo not give for more than 5 days unless directed by a doctorfind right dose on chart below. Marketed by R3 Pharmaceuticals, Llc, this product is identified by NDC 59999-001 and is authorized under FDA application part343.
Identification & Billing
- RxCUI: 307668 - acetaminophen 160 MG in 5 mL Oral Suspension
- RxCUI: 307668 - acetaminophen 32 MG/ML Oral Suspension
- RxCUI: 307668 - acetaminophen 160 MG per 5 ML Oral Suspension
- RxCUI: 307668 - acetaminophen 320 MG per 10 ML Oral Suspension
- RxCUI: 307668 - acetaminophen 650 MG per 20.3 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59999 - R3 Pharmaceuticals, Llc
- 59999-001 - Childrens Acetaminophen
- 59999-001-04 - 1 BOTTLE, PLASTIC in 1 CARTON / 118 mL in 1 BOTTLE, PLASTIC
- 59999-001 - Childrens Acetaminophen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59999-001-04 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 118 ml in 1 bottle, plastic of Childrens Acetaminophen, labeled by R3 Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by R3 Pharmaceuticals, Llc on September 23, 2013. The current certification is valid through December 31, 2017.
How is this R3 Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59999000104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.